Back

SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials

2 December 2022 (15:15 - 15:22)
Organised by:
Congress Presentation Part of: Pharmacology and Pharmacotherapy Treatment ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Prachi Sharma

King George's Medical University, Lucknow (India)

2 More presentations in this session

Presentation thumbnail
Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis
Doctor R. Cordovez (Cebu City, PH)
Abstract Slides
Presentation thumbnail
Perindopril Reduce SARS-COV-2 Spike-ACE2 Binding, ACE2 Overexpression and Cytokine Storm in Adipocyte Cell Infected with SARS-COV-2
Mr H. Hermawan (Surabaya, ID)
Abstract Slides

Access the full session

Session thumbnail
Pharmacology and Pharmacotherapy

The Event

Event poster

ESC Asia 2022 with APSC & AFC

2 December 2022 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2 inhibitors in the management of moroccan patients with heart failure with reduced ejection fraction
thumbnail
Congress Presentation
Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.
thumbnail
Congress Presentation
SGLT2 Inhibitors in patients with cancers

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources